Market closedNon-fractional

PROCEPT BioRobotics/PRCT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About PROCEPT BioRobotics

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

Ticker

PRCT

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

San Jose, United States

Employees

626

PRCT Metrics

BasicAdvanced
$3.6B
Market cap
-
P/E ratio
-$2.12
EPS
1.01
Beta
-
Dividend rate
$3.6B
1.01
8.517
7.287
30.179
31.548
-26.11%
-20.31%
-47.29%
21.545
13.46
13.52
-26.693
83.44%
-3.71%
125.05%
-44.96%

What the Analysts think about PRCT

Analyst Ratings

Majority rating from 9 analysts.
Buy

PRCT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-58.20% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$45M
2.30%
Net income
-$26M
-5.82%
Profit margin
-58.20%
-7.93%

PRCT Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 8.19%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.56
-$0.51
-$0.54
-$0.51
-
Expected
-$0.57
-$0.51
-$0.44
-$0.56
-$0.52
Surprise
-1.97%
-0.86%
23.04%
-8.19%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for PROCEPT BioRobotics stock?

PROCEPT BioRobotics (PRCT) has a market cap of $3.6B as of July 23, 2024.

What is the P/E ratio for PROCEPT BioRobotics stock?

The price to earnings (P/E) ratio for PROCEPT BioRobotics (PRCT) stock is 0 as of July 23, 2024.

Does PROCEPT BioRobotics stock pay dividends?

No, PROCEPT BioRobotics (PRCT) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next PROCEPT BioRobotics dividend payment date?

PROCEPT BioRobotics (PRCT) stock does not pay dividends to its shareholders.

What is the beta indicator for PROCEPT BioRobotics?

PROCEPT BioRobotics (PRCT) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell PROCEPT BioRobotics stock

Buy or sell PROCEPT BioRobotics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing